View all blogs:
Croda Pharma welcomes Dave Cherry
Pharma
We warmly welcome Dave Cherry as our new Global Managing Director. David brings with him past experiences from his work with the wider Life Sciences Leadership Team and healthcare markets, which is...
Introducing our Adjuvant Systems Platform
Pharma
Introducing our Adjuvant Systems platform. Leveraging a history of developing adjuvants since 1939, our scientists deliver high performance adjuvants to meet your vaccine needs today.
World Cancer Day 2023
Pharma
World Cancer Day, observed on the 4th February is led by the Union for International Cancer Control (UICC) and aims to save millions of preventable deaths each year by raising awareness and improving...
Introducing our Nucleic Acid Delivery platform
Pharma
This post introduces our Nucleic Acid Delivery platform, a technology area that was strengthened through our acquisition of Avanti Polar Lipids in 2020.
Croda Pharma: The future of novel excipients
Pharma
The importance of excipients and their specialised role in formulation development has been recognised in recent years, whether that be for targeting delivery of the drug, aesthetics of the final...
Expert Q&A - Dr Stephen Rumbelow:
Pharma
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs...
Lipid technology for delivery of gene editing therapies
Pharma
Gene-editing is one of the most eagerly anticipated biopharma developments in recent history. However, one of the biggest hurdles to the development of successful gene-editing therapeutics is...
Excipient sustainability - A user and a supplier perspective
Pharma
To achieve their sustainability ambitions excipient users need to access excipients produced with lower embedded GHG emissions, little or no waste produced and with minimal impact on water quality and...
International Human Solidarity Day
Pharma
As part of Croda’s commitment to being Climate, Land and People Positive by 2030 we have developed targets linked to the UN SDGs. This blog post will focus on our People Positive commitment. We sat...
Qualifying the EXCiPACT Certification Scheme
Pharma
There has always been a regulatory requirement for Pharmaceutical manufacturers to audit their starting material suppliers, but with increasing and sustained use of 3rd party audit solutions,...
Things to consider when choosing a cationic lipid for your formulation
Pharma
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
International Volunteer Day - Croda's STEM Programme
Pharma
In light of International Volunteer Day on the 5th of December, we highlight the Croda STEM Programme, founded on our purpose of using 'Smart science to improve lives'
Innovative lipids for your nucleic acid delivery research
Pharma
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
Introducing our Small Molecule Delivery platform
Pharma
Our offering for Small Molecule Delivery focuses on tackling your formulation challenges and enhancing drug delivery through our high purity Super Refined™ excipients. Over the years, enhancing...
Lipid Leaders: Dennis Christensen
Pharma
In this Lipid Leaders interview, we get insight from Croda Pharma's own Global Head of R&D - Adjuvant Systems, Dennis Christensen, PhD. Keep reading to learn more about adjuvants and the role they...
Croda Pharma on the road at CPHI, Frankfurt
Pharma
We recently had the pleasure of exhibiting at CPHI Frankfurt. The event spanned over three days, uniting exhibitors at the heart of pharma and thousands of attendees for an extensive exhibition and...
Proprietary purification process extends formulation shelf life
Pharma
Formulating generic drugs of equivalent stability, safety, bioequivalence, and dosage form as originator drugs can be a great challenge. James Humphrey, Research and Technology Specialist explores how...
Our Healthcare division becomes Croda Pharma
Pharma
Croda International Plc, the company that uses smart science to create high performance ingredients and solutions that improve lives, has today announced that its Health Care division will now become...
Croda Pharma wins prestigious “Best Supplier for COVID-19 Vaccine Development 2022” Award
Pharma
Croda, the company that uses smart science to improve lives, announces that it has been awarded winner a prestigious award for its work in supporting vaccine development. The company has been awarded...
Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants
Pharma
Croda International Plc, which uses smart science to improve lives, announces today that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the leading Danish Governmental...
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.